Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thermogenesis CE-marks fibrin sealant technology:

This article was originally published in Clinica

Executive Summary

Thermogenesis has CE-marked for sale in Europe its CP-2 plasma processing disposable product and FS applicator system. The CP-2 is used with the company's previously CE-marked CryoSeal CS-1 system to prepare fibrin sealant from a single unit of human plasma in about one hour. The FS applicator enables doctors to precisely apply fibrin sealant to bleeding wound sites during surgery. The Rancho Cordova, California company believes that Europe accounts for about 25% of the worldwide fibrin sealant market, which it estimates to be worth $400 million annually.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT070779

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel